Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Current HIV/AIDS Reports|July 2, 2021
Analytical Treatment Interruption in HIV Trials: Statistical and Study Design ConsiderationsLu Zheng, Camlin Tierney, Ronald J BoschAIDS (London, England)|August 8, 2013
Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatmentLei Hua, Janet W Andersen, Eric S Daar, et al.HIV Clinical Trials|April 16, 2015
Differential skeletal impact of tenofovir disoproxil fumarate in young versus old HIV-infected adultsPhilip M Grant, Douglas Kitch, Grace A McComsey, et al.Clinical Trials (London, England)|March 8, 2022
Incorporating estimands into clinical trial statistical analysis plansMinhee Kang, Michelle A Kendall, Heather Ribaudo, et al.AIDS Research and Human Retroviruses|August 9, 2002
A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298)Richard B Pollard, Camlin Tierney, Diane Havlir, et al.HIV Clinical Trials|November 3, 2011
A randomized clinical trial evaluating therapeutic drug monitoring (TDM) for protease inhibitor-based regimens in antiretroviral-experienced HIV-infected individuals: week 48 results of the A5146 studyMary Albrecht, A Lisa Mukherjee, Camlin Tierney, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 1, 2015
Brief Report: Significant Decreases in Both Total and Unbound Lopinavir and Amprenavir Exposures During Coadministration: ACTG Protocol A5143/A5147s ResultsJulie B Dumond, Joseph Rigdon, Katie Mollan, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 27, 2015
Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224sChris T Longenecker, Douglas Kitch, Paul E Sax, et al.The Journal of Infectious Diseases|January 1, 2003
Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapyCamlin Tierney, Janet L Lathey, Cindy Christopherson, et al.The Journal of Infectious Diseases|January 21, 2006
Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapyAdriana Weinberg, Camlin Tierney, Michelle A Kendall, et al.Pageof 7